Offerings // Niagen Bioscience, Inc.

NAGE offering history

Every offering-related filing in Niagen Bioscience, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 981 filings back to Jan 18, 2007.

Last executed offering

Jul 10, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Jun 29, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jul 10, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 9, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 29, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 21, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 6, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 5, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 22, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 17, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 16, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 3, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 11, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 22, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 22, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 23, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 25, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 26, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 26, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 12, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 3, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 1, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 21, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 7, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 2, 2019	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 2, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 26, 2019	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 12, 2019	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 15, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 20, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 3, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 29, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 14, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 21, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 9, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 8, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 31, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 21, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 21, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 21, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 9, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 25, 2017	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)

NAGE offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full NAGE workspace →

NAGE offering FAQ

When did NAGE last execute an offering?

Per SEC filings, Niagen Bioscience, Inc.'s most recent priced offering document is a 424B5 filed 2026-07-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did NAGE last announce or register an offering?

The most recent registration is a S-3 filed 2026-06-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.